Can Lifestyle Changes Reverse Early-Stage Alzheimer's Disease
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Catherine Madison, MD
Chief Neurologist, Preventive Medicine Research Institute
Study Director - David A Sinclair, PhD
Co-Director, Paul Glenn Labs for the Biology of Aging, Harvard Medical School
Study Director - Dean Ornish, MD
President, Preventive Med Res Inst; Clinical Prof Medicine UCSF
Principal Investigator - Douglas Galasko, MD
Professor of Neurology, University of California, San Diego
Study Director - Jonathan Artz, MD
Renown Health Institute of Neurosciences
Study Director - Jonathan Rosand, MD
Kistler Endowed Chair in Neurology, Harvard Medical School/Mass General Hospital
Study DirectorKOL profile → - Rudolph E Tanzi, PhD
Co-Director, McCance Center for Brain Health, Harvard Medical School/Mass General Hospital
Study Director - Steven E. Arnold, MD
Director, Alzheimer's Clinical and Translational Research Unit, Harvard Medical School/Mass General Hospital
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of California, San Diego
San Diego, California, United States
- Preventive Medicine Research Institute
Sausalito, California, United States
- Mccance Center for Brain Health, Harvard Medical School/mass General Hospital
Boston, Massachusetts, United States
- Renown Health Institute of Neurosciences
Reno, Nevada, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 8 Sept 2018
- Primary completion
- 30 Sept 2023
- Completion
- 30 Sept 2023
- Last update posted
- 15 Sept 2022
- Registered enrollment
- 51
- Registry id
- NCT04606420
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.